Elisabeth M. Osse

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse et al. · Clinical Cancer Research · 2016 · 858 citations

Medicine, Gynecology, Oncology +17

Practical guidance for mismatch repair-deficiency testing in endometrial cancer

Ellen Stelloo, Anna M. Jansen, Elisabeth M. Osse et al. · Annals of Oncology · 2016 · 346 citations · Full text

Medicine, Molecular Genetics, Oncology +16

<i>POLE</i> Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills et al. · Clinical Cancer Research · 2015 · 318 citations · Full text

Medicine, Immunology, Oncology +17

Adjuvant Treatment for <i>POLE</i> Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

Inge C. van Gool, Emily Rayner, Elisabeth M. Osse et al. · Clinical Cancer Research · 2018 · 71 citations · Full text

Medicine, Genetics, Oncology +11

The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

Peggy J. de Vos van Steenwijk, Mariëtte I.E. van Poelgeest, Tamara H. Ramwadhdoebé et al. · Cancer Immunology Immunotherapy · 2013 · 68 citations · Full text

Medicine, Immunology, Oncology +16